Business
Press Release Aug 24 2024
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 24, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Betamethasone Valerate Foam, 0.12%".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 24, 2024, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Betamethasone Valerate Foam, 0.12%\". View Attachment","length":382,"tagName":"div"}]